Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irene Bighelli

Showing results (11-20 of 83) with videos related to

Pageof 9
Sort By:
Psychiatry Research|July 10, 2024
The role of control groups in non-pharmacological randomised controlled trials of treatment-resistant schizophrenia: A systematic review and meta-analysisAlexandra Schütz, Nurul Husna Salahuddin, Josef Priller, et al.
The Cochrane Database of Systematic Reviews|March 12, 2024
Cognitive behavioural therapy added to standard care for first-episode and recent-onset psychosisSusanna Franziska Mayer, Ciaran Corcoran, Liam Kennedy, et al.
Journal of Psychiatric Research|October 8, 2025
Cognitive behavioral therapy for insomnia in people with schizophrenia: a systematic review and meta-analysisYuki Furukawa, Nurul Husna Salahuddin, Jingzhi Mao, et al.
BMC Psychiatry|March 6, 2020
How well do elderly patients with major depressive disorder respond to antidepressants: a systematic review and single-group meta-analysisKatharina Gutsmiedl, Marc Krause, Irene Bighelli, et al.
Schizophrenia Research|November 22, 2016
Does formulation matter? A systematic review and meta-analysis of oral versus long-acting antipsychotic studiesGiovanni Ostuzzi, Irene Bighelli, Ryuhei So, et al.
The Lancet. Psychiatry|October 1, 2023
Antipsychotic dose reduction: unclear benefits but certain risksStefan Leucht, Irene Bighelli, Spyridon Siafis, et al.
Schizophrenia (Heidelberg, Germany)|April 8, 2026
Dose reduction and discontinuation of antipsychotics in psychotic disorders: a systematic review of qualitative studies and meta-synthesisSofia Francesca Aprile, Alessandro Rodolico, Antonio Munafò, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 26, 2018
Efficacy, acceptability and tolerability of antipsychotics in patients with schizophrenia and comorbid substance use. A systematic review and meta-analysisMarc Krause, Maximilian Huhn, Johannes Schneider-Thoma, et al.
European Archives of Psychiatry and Clinical Neuroscience|December 8, 2022
Effects of psychological treatments on functioning in people with Schizophrenia: a systematic review and meta-analysis of randomized controlled trialsIrene Bighelli, Sofia Wallis, Cornelia Reitmeir, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 23, 2019
Efficacy and tolerability of pharmacological and non-pharmacological interventions in older patients with major depressive disorder: A systematic review, pairwise and network meta-analysisMarc Krause, Katharina Gutsmiedl, Irene Bighelli, et al.
Pageof 9

Showing results (11-20 of 83) with videos related to

Sort By:
Pageof 9
Psychiatry Research|July 10, 2024
The role of control groups in non-pharmacological randomised controlled trials of treatment-resistant schizophrenia: A systematic review and meta-analysisAlexandra Schütz, Nurul Husna Salahuddin, Josef Priller, et al.
The Cochrane Database of Systematic Reviews|March 12, 2024
Cognitive behavioural therapy added to standard care for first-episode and recent-onset psychosisSusanna Franziska Mayer, Ciaran Corcoran, Liam Kennedy, et al.
Journal of Psychiatric Research|October 8, 2025
Cognitive behavioral therapy for insomnia in people with schizophrenia: a systematic review and meta-analysisYuki Furukawa, Nurul Husna Salahuddin, Jingzhi Mao, et al.
BMC Psychiatry|March 6, 2020
How well do elderly patients with major depressive disorder respond to antidepressants: a systematic review and single-group meta-analysisKatharina Gutsmiedl, Marc Krause, Irene Bighelli, et al.
Schizophrenia Research|November 22, 2016
Does formulation matter? A systematic review and meta-analysis of oral versus long-acting antipsychotic studiesGiovanni Ostuzzi, Irene Bighelli, Ryuhei So, et al.
The Lancet. Psychiatry|October 1, 2023
Antipsychotic dose reduction: unclear benefits but certain risksStefan Leucht, Irene Bighelli, Spyridon Siafis, et al.
Schizophrenia (Heidelberg, Germany)|April 8, 2026
Dose reduction and discontinuation of antipsychotics in psychotic disorders: a systematic review of qualitative studies and meta-synthesisSofia Francesca Aprile, Alessandro Rodolico, Antonio Munafò, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 26, 2018
Efficacy, acceptability and tolerability of antipsychotics in patients with schizophrenia and comorbid substance use. A systematic review and meta-analysisMarc Krause, Maximilian Huhn, Johannes Schneider-Thoma, et al.
European Archives of Psychiatry and Clinical Neuroscience|December 8, 2022
Effects of psychological treatments on functioning in people with Schizophrenia: a systematic review and meta-analysis of randomized controlled trialsIrene Bighelli, Sofia Wallis, Cornelia Reitmeir, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 23, 2019
Efficacy and tolerability of pharmacological and non-pharmacological interventions in older patients with major depressive disorder: A systematic review, pairwise and network meta-analysisMarc Krause, Katharina Gutsmiedl, Irene Bighelli, et al.
Pageof 9